Biolife Solutions [BLFS] vs Becton, Dickinson [BDX] Detailed Stock Comparison

Biolife Solutions Inc.

NASDAQ
Loading...

Becton, Dickinson and Company

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Biolife Solutions Inc. wins in 3 metrics, Becton, Dickinson and Company wins in 15 metrics, with 0 ties. Becton, Dickinson and Company appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Biolife Solutions Inc. Becton, Dickinson and Company Better
P/E Ratio (TTM) N/A 25.40 N/A
Price-to-Book Ratio 2.77 1.75 Becton, Dickinson and Company
Debt-to-Equity Ratio 4.81 77.28 Biolife Solutions Inc.
PEG Ratio 73.72 0.92 Becton, Dickinson and Company
EV/EBITDA 266.67 10.49 Becton, Dickinson and Company
Profit Margin (TTM) -4.78% 8.01% Becton, Dickinson and Company
Operating Margin (TTM) -0.32% 13.35% Becton, Dickinson and Company
EBITDA Margin (TTM) N/A 13.35% N/A
Return on Equity -3.37% 6.96% Becton, Dickinson and Company
Return on Assets (TTM) -0.17% 4.08% Becton, Dickinson and Company
Free Cash Flow (TTM) $416,000 $2.67B Becton, Dickinson and Company
Dividend Yield N/A 2.56% N/A
1-Year Return 13.89% 8.43% Biolife Solutions Inc.
Price-to-Sales Ratio (TTM) 10.73 2.57 Becton, Dickinson and Company
Enterprise Value $961.62M $63.40B Becton, Dickinson and Company
EV/Revenue Ratio 10.00 2.89 Becton, Dickinson and Company
Gross Profit Margin (TTM) 63.76% 45.91% Biolife Solutions Inc.
Revenue per Share (TTM) $2 $76 Becton, Dickinson and Company
Earnings per Share (Diluted) $-0.25 $6.13 Becton, Dickinson and Company
Beta (Stock Volatility) 2.00 0.35 Becton, Dickinson and Company
Short % of Float 10.51% 3.78% Becton, Dickinson and Company

Biolife Solutions Inc. vs Becton, Dickinson and Company Stock Performance Analysis

Loading Price Chart...

BLFS
BDX

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Biolife Solutions Inc.-0.87%14.40%30.35%22.07%8.36%15.07%
Becton, Dickinson and Company0.82%-2.25%-1.28%-18.19%-3.55%-5.76%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Biolife Solutions Inc.13.89%7.41%-24.37%1,467.30%2,442.86%2,442.86%
Becton, Dickinson and Company8.43%-25.68%-20.29%13.34%123.65%215.10%

Performance & Financial Health Analysis: Biolife Solutions Inc. vs Becton, Dickinson and Company

MetricBLFSBDX
Market Information
Market Cap i$1.03B$56.10B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i418,3152,759,250
90 Day Avg. Volume i388,6582,521,130
Last Close$27.25$145.61
52 Week Range$17.86 - $29.62$127.59 - $187.35
% from 52W High-8.00%-22.28%
All-Time High$1,382.50 (Nov 04, 1991)$287.32 (Jul 24, 2023)
% from All-Time High-98.03%-49.32%
Growth Metrics
Quarterly Revenue Growth0.64%0.02%
Quarterly Earnings Growth-0.11%0.26%
Financial Health
Profit Margin (TTM) i-0.05%0.08%
Operating Margin (TTM) i0.00%0.13%
Return on Equity (TTM) i-0.03%0.07%
Debt to Equity (MRQ) i4.8177.28
Cash & Liquidity
Book Value per Share (MRQ)$7.72$88.79
Cash per Share (MRQ)$1.84$2.64
Operating Cash Flow (TTM) i$20.12M$3.39B
Levered Free Cash Flow (TTM) i$12.44M$3.11B
Dividends
Last 12-Month Dividend Yield iN/A2.56%
Last 12-Month Dividend iN/A$4.18

Valuation & Enterprise Metrics Analysis: Biolife Solutions Inc. vs Becton, Dickinson and Company

MetricBLFS (Apr 26, 2026)BDX (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) iN/A25.40
Forward P/E i73.7211.53
PEG Ratio i73.720.92
Price to Sales (TTM) i10.732.57
Price to Book (MRQ) i2.771.75
Market Capitalization
Market Capitalization i$1.03B$56.10B
Enterprise Value i$961.62M$63.40B
Enterprise Value Metrics
Enterprise to Revenue i10.002.89
Enterprise to EBITDA i266.6710.49
Risk & Other Metrics
Beta i2.000.35
Book Value per Share (MRQ) i$7.72$88.79

Financial Statements Comparison: Biolife Solutions Inc. vs Becton, Dickinson and Company

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricBLFS (2025)BDX (2025)
Revenue/Sales i96.21M21.84B
Cost of Goods Sold i34.10M11.92B
COGS % of Revenue i35.4%54.6%
Gross Profit i62.12M9.93B
Gross Margin i64.6%45.4%
Research & Development i23.09M1.27B
Operating Income (EBIT) i-16.60M2.99B
Operating Margin i-17.3%13.7%
EBITDA i-11.92M5.42B
EBITDA Margin i-12.4%24.8%
Pre-Tax Income i-12.08M1.88B
Pre-Tax Income % of Revenue i-12.6%8.6%
Income Tax i49,000203.00M
Income Tax % of Revenue i0.1%0.9%
Net Income (Profit) i-4.60M1.68B
Profit Margin i-4.8%7.7%

Balance Sheet & Liquidity Metrics

MetricBLFS (2025)BDX (2025)
Cash & Equivalents i33.04M641.00M
Total Current Assets i136.56M9.26B
Total Current Assets % of Revenue i141.9%42.4%
Total Current Liabilities i22.98M8.31B
Total Current Liabilities % of Revenue i23.9%38.1%
Long-Term Debt i10.66M17.62B
Long-Term Debt % of Revenue i11.1%80.7%
Total Shareholders Equity i371.89M25.39B
Retained Earnings i-339.70M16.62B
Retained Earnings % of Revenue i-353.1%76.1%
Property, Plant & Equipment i12.07M0

Cash Flow Statement Comparison

MetricBLFS (2025)BDX (2025)
Operating Cash Flow i37.73M3.68B
Operating Cash Flow % of Revenue i39.2%16.9%
Capital Expenditures i-9.48MN/A
Free Cash Flow i416,0002.67B
FCF Margin i0.4%12.2%
Debt Repayment i-10.00M-1.79B
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricBLFSBDX
Shares Short i3.60M9.49M
Short Ratio i7.403.92
Short % of Float i10.51%3.78%
Shares Outstanding i48.20M284.74M
Float Shares i40.63M283.99M
% Held by Insiders i2.61%0.40%
% Held by Institutions i106.48%96.58%
% Held by Public i-9.09%3.02%

Dividend Analysis & Yield Comparison: Biolife Solutions Inc. vs Becton, Dickinson and Company

MetricBLFSBDX
Last 12-Month Dividend iN/A$4.18
Last 12-Month Dividend Yield iN/A2.56%
3-Year Avg Annual Dividend iN/A$3.96
3-Year Avg Dividend Yield iN/A0.58%
3-Year Total Dividends iN/A$11.88
Ex-Dividend DateN/AMar 10, 2026